Clinical Trial Update: The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD

View source ↗

Summary

This clinical trial update reports the long-term safety and efficacy follow-up of subjects who completed the Phase I study of Neurostem-AD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Neurodegenerative Diseases
• Tauopathies

Drugs mentioned

• NEUROSTEM-AD

Snippet

Sponsor: Duk Lyul Na | Conditions: Alzheimer Disease, Dementia | Status: UNKNOWN